The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Kaplan, Muhammet; Oruc, Zeynep; Gumus, Mahmut; Ozaydm, Sukru; ELKIRAN, EMİN; Dine, Nur; Sakin, Abdullah; Berk, Veli; Akman, Tulay; Aytekin, Aydin; Yazilitas, Dogan; Dane, Faysal; Imamoglu, Goksen; Cubukce, Erdem; Isikdogan, Abdurrahman

The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Atıf İçin Kopyala

Kaplan M. A., Oruc Z., Gumus M., Ozaydm S., ELKIRAN E. T., Dine N. S., ...Daha Fazla

JOURNAL OF BUON, cilt.24, sa.3, ss.1081-1086, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24 Sayı: 3
Basım Tarihi: 2019
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1081-1086
Anahtar Kelimeler: paclitaxel, anthracycline, adjuvant, breast cancer, DOXORUBICIN PLUS CYCLOPHOSPHAMIDE, PHASE-III, DOCETAXEL, OUTCOMES, THERAPY, TAXANES, TRIAL
Gazi Üniversitesi Adresli: Evet

Özet

Purpose: To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-based chemotherapy and paclitaxel.